Quercus Molecular Design
Research at the interface between chemistry and biology is opening new avenues to explore the roles of proteins associated with disease. What is emerging holds exciting promise for development of new, potent drug therapies.
We have assembled a team with extensive business and academic experience in molecular virology, drug resistance, cancer therapeutics, and medicinal chemistry. With our knowledge of the proteins associated with disease states, we aim to discover and develop small molecule inhibitors that simultaneously inhibit (or target) two or more essential proteins to treat infectious diseases and cancer. This approach is expected to both enhance potency and slow the onset of resistance. Our business is to develop new therapeutic agents based on this multi-targeting platform.
Announcements More news Projects
